Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
North American Ginseng in Hypertension
NCT00219960Phase 3Completed
- Sponsor
- Risk Factor Modification Centre
- Start
- Apr 2001
- Modality
- BDS (Botanical Dietary Supplement)
- Countries
- 1
01
Overview
A Phase 3 trial of panax quinquefolius in hypertension (HTN), sponsored by Risk Factor Modification Centre. Started Apr 2001; status: completed.
02
Drugs
panax quinquefolius
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00219960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219960.